Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (171-180 of 374) with videos related to

Pageof 38
Sort By:
Journal of Patient Safety|October 3, 2014
Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk KnowledgeCornelis A van den Bogert, Michael J Miller, Daniel J Cobaugh, et al.
Medicare & Medicaid Research Review|May 7, 2014
Evaluating comorbidity scores based on health service expendituresMeredith L Kilgore, Wilson Smith, Jeffrey R Curtis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2012
A close examination of healthcare expenditures related to fracturesMeredith L Kilgore, Jeffrey R Curtis, Elizabeth Delzell, et al.
Journal of General Internal Medicine|June 25, 2009
Population-based fracture risk assessment and osteoporosis treatment disparities by race and genderJeffrey R Curtis, Leslie A McClure, Elizabeth Delzell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2017
Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United StatesJeffrey R Curtis, Fenglong Xie, Christian Smith, et al.
Arthritis Research & Therapy|September 23, 2016
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
The New England Journal of Medicine|November 16, 2007
Teriparatide or alendronate in glucocorticoid-induced osteoporosisKenneth G Saag, Elizabeth Shane, Steven Boonen, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®)Edward S Leib, Kenneth G Saag, Jonathan D Adachi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2014
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spineNicole C Wright, Anne C Looker, Kenneth G Saag, et al.
Mayo Clinic Proceedings|July 14, 2006
Gout medication treatment patterns and adherence to standards of care from a managed care perspectiveChaitanya A Sarawate, Kathleen K Brewer, Wenya Yang, et al.
Pageof 38

Showing results (171-180 of 374) with videos related to

Sort By:
Pageof 38
Journal of Patient Safety|October 3, 2014
Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk KnowledgeCornelis A van den Bogert, Michael J Miller, Daniel J Cobaugh, et al.
Medicare & Medicaid Research Review|May 7, 2014
Evaluating comorbidity scores based on health service expendituresMeredith L Kilgore, Wilson Smith, Jeffrey R Curtis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2012
A close examination of healthcare expenditures related to fracturesMeredith L Kilgore, Jeffrey R Curtis, Elizabeth Delzell, et al.
Journal of General Internal Medicine|June 25, 2009
Population-based fracture risk assessment and osteoporosis treatment disparities by race and genderJeffrey R Curtis, Leslie A McClure, Elizabeth Delzell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2017
Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United StatesJeffrey R Curtis, Fenglong Xie, Christian Smith, et al.
Arthritis Research & Therapy|September 23, 2016
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
The New England Journal of Medicine|November 16, 2007
Teriparatide or alendronate in glucocorticoid-induced osteoporosisKenneth G Saag, Elizabeth Shane, Steven Boonen, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®)Edward S Leib, Kenneth G Saag, Jonathan D Adachi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2014
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spineNicole C Wright, Anne C Looker, Kenneth G Saag, et al.
Mayo Clinic Proceedings|July 14, 2006
Gout medication treatment patterns and adherence to standards of care from a managed care perspectiveChaitanya A Sarawate, Kathleen K Brewer, Wenya Yang, et al.
Pageof 38